Patients with proliferative nephritis (WHO class III or IV) had a greater reduction of anti-CRP antibody levels compared with patients with membranous (WHO class V) nephritis (Figure 3), although this was not statistically significant (P = 0.08). Here, CRP is linked to nephritis.